SIGA Technologies, Inc.

SIGA Technologies, Inc.

  • 420 Lexington Ave Ste 601
  • New York, New York
  • 10170
  • Phone: (212) 672-9100
  • Fax: (541) 753-9999
  • Website

Website Links

Description

Jeffrey B. Kindler has served as a director of SIGA since March 2013. Mr. Kindler is the CEO of Centrexion, a privately held clinical stage biopharmaceutical company; a Venture Partner at Lux Capital, a leading venture capital firm; and a director at Starboard Capital Partners, a Connecticut-based private equity firm.

In the US and around the globe, populations face a serious but unmet need for new drugs to protect against potentially catastrophic emerging viral pathogens and biological weapons of mass destruction. SIGA Technologies is a pharmaceutical company specializing in developing therapeutic solutions for some of the most lethal pathogens – variola (smallpox), Ebola, dengue, Lassa fever and other dangerous viruses. Our business is to discover and develop drugs to prevent and treat these high-priority threats. Our mission is to create robust, modern countermeasures to dreaded viral diseases.

SIGA is a pharmaceutical company specializing in the development of pharmaceutical solutions for some of the most lethal pathogens – variola (smallpox), Ebola, dengue, Lassa fever and other dangerous viruses. Our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority threats. Our mission is to disarm dreaded viral diseases and create robust, modern biodefense countermeasures.

At SIGA, we specialize in developing therapeutic solutions for some of the most lethal pathogens – smallpox, Ebola, dengue, Lassa fever and other dangerous viruses. Our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority threats.

NEW YORK, March 1, 2013 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight lethal disease causing pathogens, announced today that management will host a conference call and simultaneous webcast to provide a quarterly business update at 4:30 P.M. EST on Wednesday, Ma...

Fact sheet

Number of employees
60
Annual revenue
$14000000

Company contacts

  • Dennis Hruby
  • Manager

Products & services

Similar companies nearby